Ali Yildiz, President of Protect Pharmaceutical Corp., Issues Letter to Shareholders
- None.
- None.
ISTANBUL, Turkey, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Protect Pharmaceutical Corp.’s (OTC: PRTT) President, Ali Yildiz, publishes a letter to Company Shareholders as follows:
“Dear Shareholders of Protect Pharmaceutical Corp.:
We have continued working with respect to finalizing our PCAOB audit. Our auditor has been granted access to the remaining areas that were needed and is finalizing the audit now. We are expecting the finalization of our audit for the calendar years 2021 and 2022 within the next few days. We are also preparing our year end numbers for 2023 to be audited. We will provide shareholders with the audit reports promptly upon receiving the finalized 2021 and 2022 reports.
We are also proud to report that shipments to Azerbaijan have greatly increased proceeding our recent acquisition on Bosfor Export. Our shipments to the country have increased by over
We are excited for the new year and the new opportunities that lie ahead. As we complete our audit and continue with our record growth in revenue and profitability, we believe we will be positioned well in the industry.”
About Atlantic Logistics:
At Atlantic Logistics we strive to provide innovation in service. We strive to provide a business model that gives our customers and partners the technology and commercial intelligence to support creative ideas. We have a team dedicated to keeping our systems on the cutting edge and constantly evolving our business to better serve our clients. We use robust technology to track inventories, manage customs compliance and track shipments throughout the world. Atlantic Logistics is the answer for any logistics needs you might have. We transport products via land, air and sea using trucks, ships, rail and air. We are rapidly growing into a worldwide logistics company and have services now across Europe, Asia, South America, and Central America - https://www.atlantic-logistics.net/
Forward-Looking Statements: This press release contains “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934. Except for historical matters contained herein, statements made in this press release are forward-looking statements. Without limiting the generality of the foregoing, words such as “may”, “will”, “to”, “plan”, “expect”, “believe”, “anticipate”, “intend”, “could”, “would”, “estimate,” or “continue”, or the negative other variations thereof or comparable terminology are intended to identify forward-looking statements. Forward-looking statements involve known and unknown risk, uncertainties and other factors which may cause our actual results, performance, or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Also, forward-looking statements represent our management’s beliefs and assumptions only as of the date hereof. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in the Company's filings with OTC Markets. Except as required by law, we assume no obligation to update these forward-looking statements publicly or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
For more information contact:
Protect Pharmaceutical Corp.
Ali Yildiz +90 (531) 452 82 27
Info@atlantic-logistics.net
www.atlantic-logistics.net
FAQ
What did Ali Yildiz update shareholders about?
What is the ticker symbol for Protect Pharmaceutical Corp.?
What is the expected impact of increased shipments to Azerbaijan?
What is the company's focus for the new year?
What is the significance of the increased profitability and revenues through valuable routes?